Dr. Lauren R. Natbony, Integrative Headache Medicine of New York

03/18/2026

“You’ve tried everything.”
“Nothing else will work.”
“You’re out of options.”

Many people living with migraine have heard some version of this.

But in most cases, it simply isn’t true.

My interview for the Migraine World Summit is now live:
“Told You’re Out of Options? There’s Hope.”

In this conversation we talk about what “treatment resistant” migraine actually means and why many people are labeled this way too quickly.

We also discuss medication overuse headache, integrative approaches that can work alongside medication, and practical strategies for navigating chronic migraine when treatments have not worked the way you hoped.

Migraine care is evolving. New treatments and broader approaches are opening doors that did not exist before.

If you live with migraine, I hope this conversation offers perspective and hope.

Have you ever been told you were “out of options”?

I would love to hear your experience in the comments.

11/15/2025

Migraine rarely travels alone.
It often overlaps with other chronic conditions like POTS, IBS, MCAS, and EDS, and understanding those connections can change how we treat and manage symptoms.

Join me and for an Instagram Live on Friday Dec 12th at 4:30 PM ET.

We’ll unpack how migraine interacts with the gut, immune system, and autonomic nervous system and what you can actually do about it.

This event is sponsored by

Bring your questions. This one’s going to be good.
Scan the QR code to register.

03/22/2025

Want to learn more about migraine and sleep? Come check out my interview at Migraine World Summit

Explore the link between sleep disorders and migraine, plus tips for better rest from Dr. Lauren R. Natbony.

06/27/2024

Exciting news! I’ve partnered with Rosy to create the Headache & Migraine Collection. Four free modules to help women understand and manage migraine. Grateful to the Rosy team!

Check out the collection!
🔗meetrosy.com/hmcollection

🤯 1 in 5 women worldwide suffer from migraine. Problem is: people often confuse a migraine attack with a bad headache. As a result, millions of women go through life undiagnosed and untreated.

So they don’t seek out medical help. Instead, they suffer in silence. Pop an ibuprofen. And just try to tough it out by still attending that work meeting or social event they committed to…

Our brand new (free) Headache and Migraine Collection is now live in the app! 🚀 If you or a loved one struggles with recurrent headaches or migraine attacks, this Collection is for you.

In 4, bite-sized modules created in collaboration with internationally renowned headache specialist Dr. Lauren R. Natbony, Integrative Headache Medicine of New York, you’ll learn what causes migraine in women and science-backed strategies to manage and prevent attacks.

🔎 Explore the new Collection now: https://meetrosy.com/headache-migraine-collection

06/30/2023

It's the last day of National Migraine and Headache Awareness Month, and I'm glad to have been able to share my migraine toolbox tips with !

📖Check out the full article in my bio for advice on how to be prepared when a migraine strikes.

🤔So what's in your migraine toolbox? We want to hear your go-to favorites! Share them in the comments below.

03/08/2023

Wondering where you’ll be tomorrow at 3pm eastern? Watching me speak at the Migraine World Summit of course! Register now at https://migraineworldsummit.com

01/26/2023

I am thrilled to announce that I've signed an Investigator Initiated Research Agreement with to study the tolerability and efficacy of their proprietary psilocin compound L-130, in patients suffering from Cluster Headaches (CH). I am excited to evaluate the impact of Lobe’s psilocin compound, L-130, in treating these devastating headaches to bring relief to more CH sufferers everywhere! ⁠
⁠
More to come over the next few months as I dive in. The data reported in the literature supports the use of psilocybin in CH patients, and since L-130 is the active metabolite of psilocybin, it appears to be an efficient way of delivering non-psychedelic doses of psilocin with potentially better bioavailability and consistency. Using sub-psychedelic dosing may allow physicians a therapeutic solution to a devastating condition where treatment options are limited.⁠
⁠
Honored to be devoting my expertise in advancing migraine relief in these new and exciting ways. Thank you to Lobe Sciences for this incredible partnership!⁠
⁠
⁠
⁠
⁠
⁠